Viewing Study NCT00566618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2026-03-01 @ 9:45 AM
Study NCT ID: NCT00566618
Status: COMPLETED
Last Update Posted: 2022-02-25
First Post: 2007-11-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Bone Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Bone Metastases View
None Breast Cancer with Bone Metastases View
None Breast Cancer with Metastases to Bone View
None Dasatinib View
None Zometa View
None Zoledronic Acid View
None Zoledronate View
None BMS-345825 View
None Sprycel® View